GlassScriptPhysician profile
Lawrence Hodor
NPI 1235152794
$10,955.86
in general payments reported to CMS, 2019-2025
42 companies · $893 in 2025
The $893 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,949 · 2020: $646 · 2021: $915 · 2022: $1,706 · 2023: $1,852 · 2024: $994 · 2025: $893.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,738.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,738.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Micromed INC | $2,813.11 | 2019-2021 | |
| Integra Lifesciences Corporation | $1,294.15 | 2019-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Smith+Nephew, INC. | $1,121.58 | 2019-2024 | Grafix Pl, Pico 14, Renasys Go V2 Home |
| Stryker Corporation | $769.04 | 2019-2025 | Easyfuse, Augment Injectable |
| Biotissue Holdings INC. | $664.43 | 2021-2025 | |
| Zimmer Biomet Holdings, INC. | $390.94 | 2019-2022 | |
| Organogenesis INC. | $353.75 | 2021-2023 | Puraply |
| Extremity Medical | $320.27 | 2019-2023 | Io Fix |
| Depuy Synthes Sales INC. | $279.62 | 2023-2025 | Crosstie, Hammerlock, Motoband |
| Mimedx Group, INC. | $274.41 | 2024-2025 | |
| Janssen Pharmaceuticals, INC | $235.03 | 2019-2020 | |
| Horizon Therapeutics Plc | $205.96 | 2019-2023 | Krystexxa |
| Boston Scientific Corporation | $189.80 | 2019-2021 | |
| Bioventus LLC | $175.66 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Paratek Pharmaceuticals, INC. | $158.55 | 2021-2024 | Nuzyra |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovation Technologies INC | $156.91 | 2025 | Irrisept |
| Linvatec Corporation | $151.07 | 2024 | Biobrace 23mm |
| Kerecis Limited | $148.25 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Acumed LLC | $123.00 | 2024 | Acumed |
| Idorsia Pharmaceuticals US INC | $120.89 | 2023 | Quviviq |
| Arthrex, INC. | $107.59 | 2020 | |
| Treace Medical Concepts, INC. | $92.07 | 2025 | |
| Abbvie INC. | $91.27 | 2021-2024 | |
| Globus Medical, INC. | $91.20 | 2021-2023 | Mini Fragment System, Ankle Fracture System |
| Kci USA, INC. | $69.42 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $69.11 | 2019-2022 | |
| Abbott Laboratories | $61.89 | 2023-2024 | Eterna, Proclaim |
| Reprise Biomedical, INC. | $55.06 | 2023 | Miro3d |
| Medline Industries LP | $52.17 | 2022-2023 | |
| Solventum Corporation | $49.09 | 2024 | V.A.C. Veraflo Cleanse Choice, Prevena, V.A.C. Veraflo |
| Averitas Pharma INC. | $41.07 | 2024 | Qutenza |
| Wright Medical Technology, INC. | $40.34 | 2019-2020 | |
| Nevro Corp. | $36.15 | 2022-2023 | Senza |
| Osiris Therapeutics INC. | $23.75 | 2019 | |
| Molnlycke Health Care US, LLC | $22.44 | 2022 | |
| Convatec INC. | $21.24 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $19.66 | 2020 | |
| Novo Nordisk INC | $19.40 | 2023 | Ozempic |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.79 | 2019 | |
| Avanos Medical | $14.70 | 2022 | |
| Orthofix Medical, INC. | $12.35 | 2025 | Physio-Stim |
| Paragon 28, INC. | $4.68 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Hodor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.